Development by Fernandez-Miranda, G (author) et al.
2661RESEARCH ARTICLE
INTRODUCTION
Progression through the cell cycle requires the controlled activation
of different families of kinases that regulate diverse cellular
processes required for cell division. Early work in Drosophila led
to the identification of aurora mutants, which carry a loss-of-
function mutation in a serine/threonine kinase essential for
centrosome separation and the formation of bipolar spindles
(Glover et al., 1995). A single aurora protein exists in budding
(increase-inploidy 1; Ipl1) or fission (Ark1) yeast, whereas two
family members, aurora A and aurora B, are present in worms, flies
and frogs. Three different aurora family members, known as aurora
A, B and C, exist in mammals (Nigg, 2001). Aurora B and C are
close paralogs that probably arose from a cold-blooded vertebrate
common ancestor (Brown et al., 2004).
Aurora kinases participate in multiple processes during the
mammalian cell cycle (Carmena and Earnshaw, 2003). Aurora A is
required for building a bipolar spindle regulating centrosome
separation and microtubule dynamics (Barr and Gergely, 2007;
Giet et al., 2005). Aurora B belongs to the chromosome passenger
complex (CPC) that localizes to the kinetochores from prophase to
metaphase and to the central spindle and midbody in cytokinesis
(Carmena and Earnshaw, 2003; Ruchaud et al., 2007). Other
mammalian CPC proteins include the inner centromere protein
incenp, survivin and borealin, which control the targeting,
enzymatic activity and stability of aurora B (Ruchaud et al., 2007).
The CPC is one of the most upstream regulators of centromere and
kinetochore function, being responsible for the recruitment to the
kinetochore and centromere of a growing number of proteins,
including inner centromeric proteins (Sgo1, Sgo2, MCAK),
regulators of the microtubule-kinetochore interaction [such as
Ndc80 (HEC1), CENP-E or Plk1 among others] or proteins
involved in the spindle assembly checkpoint (SAC; such as Mad2,
BubR1 or Mps1) (for a review, see Kelly and Funabiki, 2009).
Some of these molecules, including Ndc80, Dam1 and MCAK, are
aurora B substrates suggesting a crucial role for the CPC in the
destabilization of aberrant microtubule-to-kinetochore attachments
and the SAC-dependent delay until these defects are corrected
(Nezi and Musacchio, 2009). During cytokinesis, aurora B is
localized to the midbody remnant where its local inactivation is
crucial for completion of abscission (Guse et al., 2005; Steigemann
et al., 2009). Aurora B also participates in mitotic phosphorylation
of Ser10 and, probably, Ser 28 in histone H3. These events seem
to be necessary for chromosome condensation although the
correlation between H3S10 phosphorylation and the condensation
of chromosomes is not fully established (Johansen and Johansen,
2006; Nowak and Corces, 2004; Prigent and Dimitrov, 2003). Less
is known about aurora C, which can also bind members of the CPC
(Li et al., 2004) and its ectopic expression can rescue aurora B loss
of function in cultured cells (Sasai et al., 2004; Slattery et al., 2009;
Slattery et al., 2008; Yan et al., 2005). Although aurora C is known
to have a specific role in spermatogenesis (Dieterich et al., 2007;
Kimmins et al., 2007; Tang et al., 2006) and oogenesis (Sharif et
al., 2010), its physiological relevance in the regulation of mitosis
is not well understood.
In mammals, the CPC seems to be required for early embryonic
development and embryos degenerate by E2.5-3.5 in the absence
of the CPC components survivin (Uren et al., 2000), incenp (Cutts
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SUMMARY
Mitosis is controlled by multiple kinases that drive cell cycle progression and prevent chromosome mis-segregation. Aurora kinase
B interacts with survivin, borealin and incenp to form the chromosomal passenger complex (CPC), which is involved in the
regulation of microtubule-kinetochore attachments and cytokinesis. Whereas genetic ablation of survivin, borealin or incenp
results in early lethality at the morula stage, we show here that aurora B is dispensable for CPC function during early cell divisions
and aurora B-null embryos are normally implanted. This is due to a crucial function of aurora C during these early embryonic
cycles. Expression of aurora C decreases during late blastocyst stages resulting in post-implantation defects in aurora B-null
embryos. These defects correlate with abundant prometaphase figures and apoptotic cell death of the aurora B-deficient inner
cell mass. Conditional deletion of aurora B in somatic cells that do not express aurora C results in chromosomal misalignment and
lack of chromosome segregation. Re-expression of wild-type, but not kinase-dead, aurora C rescues this defect, suggesting
functional overlap between these two kinases. Finally, aurora B-null cells partially arrest in the presence of nocodazole,
suggesting that this kinase is not essential for the spindle assembly checkpoint.
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Genetic disruption of aurora B uncovers an essential role for
aurora C during early mammalian development
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et al., 1999) or borealin (Yamanaka et al., 2008). We report here
that aurora B-null embryos develop normally during the early cell
divisions and die only after implantation, suggesting the presence
of normal cell cycles in the early embryonic cell divisions in the
absence of aurora B. Interestingly, aurora C is highly expressed
during the early cell divisions and it seems to be responsible for
CPC function in these pre-implantation embryos. After
implantation, aurora B-defective embryos and somatic cells
accumulate prometaphase/metaphase figures eventually leading to
apoptotic cell death. The cellular defects induced by acute
elimination of aurora B in somatic cells can be rescued by re-
expressing active aurora C. Finally, we also show that aurora B-
null cells can still arrest in the absence of microtubules, suggesting
that this protein is not essential for the SAC.
MATERIALS AND METHODS
Aurora B-targeted mice
The conditional targeting construct was assembled by flanking exons 2-6
of the murine Aurkb locus with loxP sequences (Fig. 1A). An additional
knock-in that expresses the -galactosidase (lacZ) gene was generated (Fig.
1 and see Fig. S1 in the supplementary material) following the FLEx
strategy as reported previously (Schnutgen et al., 2003). Tg.pCAG–Flpe
(Rodriguez et al., 2000) or Tg.CMV-Cre (Schwenk et al., 1995) transgenic
mice were used for ubiquitous expression of Flp or Cre recombinases. All
animals were maintained in a mixed 129/Sv (25%)  CD1 (25%) 
C57BL/6J (50%) background following the animal care standards of the
institution (Ethical Committee ISCIII). Genotyping protocols are available
upon request (see also Fig. S1 in the supplementary material).
Immunohistochemical examination of the tissues and pathologies analyzed
were performed using specific antibodies against aurora B (Abcam), aurora
C (Invitrogen), phospho-p53 (Ser15; Cell Signaling), -H2AX (Ser139;
Millipore), active caspase 3 (R&D Systems), cyclin B1 (Millipore), Sox2
(Millipore) and GATA4 (Santa Cruz Biotechnology). Other routine
histological techniques and the quantification of DNA ploidy in sections
was performed as described previously (Garcia-Higuera et al., 2008).
Culture and transfection of embryos
Fertilized embryos at E1.5-2.5 were collected by flushing the uteri of
pregnant females with M2 medium (Sigma) and cultured in vitro in
potassium simplex optimized medium (KSOM; Chemicon International).
To generate outgrowths of the inner cell mass, blastocyts were transferred
into gelatinized 96-well plates and cultured in embryonic stem (ES) cell
medium [DMEM + GlutaMAX, 15% fetal bovine serum (FBS), non-
essential amino acids] for several days. Two-cell embryos were incubated
with ZM447439 drug (abbreviated as ZM1, Tocris Bioscience) and
cultured in vitro for 2 days. For RNA interference in embryos, pronuclei
were injected (Leica DMIRE2/ASTP) with pA70 plasmids (a modified
Gateway-compatible version of pSuper-Retro plasmid) expressing either
shAurB, shAurC or shLuciferase interfering RNAs at a final DNA
concentration of 16 ng/l. In all cases, a H2B-EGFP-expressing plasmid
(4ng/l) was co-injected. The targeted sequences for aurora B and C are
the following: shAurB-1, 5-GTTGGCTGAGAACAAGAGT-3; shAurB-
2, 5-GAGCCGTTTCATCGTGGCA-3; shAurB-3, 5-CAAGAGTC -
AGGGCTCCACT-3; shAurC-1, 5-GGAAAATCATTTCATCGTG-3;
shAurC-2, 5-CCAGGAAGCATTTCACCAT-3; and shAurC-3, 5-
GCTTCTTAGGTACCATCCT-3. Total RNA was isolated using Trizol
(Invitrogen) and gene expression was quantified with the SuperScript III
Platinum Assay Kit (Invitrogen), according to the manufacturer’s
instructions, in a BioRad iCycler Real-Time PCR apparatus. Data analysis
was performed using the iQ5 v. 2.0 software (BioRad).
Primary mouse embryo fibroblasts (MEFs)
MEFs were obtained from E14.5 embryos and cultured using routine
protocols (Garcia-Higuera et al., 2008). The adenoviruses expressing GFP
or the Cre recombinase (Ad5 CMV-Cre) were obtained from The
University of Iowa (Iowa City, IA, USA). Infection was carried out for 2
days in cell culture synchronized in G0 by serum deprivation and
confluence. DNA content was analyzed by flow cytometry (FACS; Becton-
Dickinson). The duration of mitosis was scored by videomicroscopy using
Deltavision apparatus. Nocodozole (Sigma) was used at 3.5 M to
completely prevent the formation of microtubules. The mouse aurora C
cDNA was amplified by RT-PCR (Superscript II Reverse Transcriptase,
Invitrogen) from mouse testis RNA and cloned as GFP- or V5-fusions as
described previously (Fernandez-Miranda et al., 2010). The aurora C
kinase-dead mutant (K45M) was prepared using the Quick-Change Site
Mutagenesis Kit (Invitrogen). The wild-type and kinase-dead (D205A)
aurora B cDNAs were described previously (Fernandez-Miranda et al.,
2010). For rescue experiments, primary MEFs were first transduced with
Cre adenovirus in G0 and 48 hours later they were transfected with GFP-
aurora B/C constructs using the Amaxa nucleofection technology (Lonza
AG) and seeded in 10% FBS to start a new cell cycle. Mad2 expression
was knocked down using specific small interference (si) RNAs from
Dharmacon.
Immunofluorescence and protein analysis
For immunofluorescence, embryos were fixed with cold methanol or 5%
paraformaldehyde (PFA), rinsed with M2 medium, washed in PBS
containing 0.1% bovine serum albumin (BSA; Sigma) and incubated with
0.1% Triton X-100 for permeabilization. MEFs were fixed with 4% PFA
and permeabilized with 0.15% Triton X-100. Embryos or MEFs were then
blocked with 3% BSA and incubated with anti-centromere antibody (ACA;
Antibodies Incorporated) or primary antibodies against -tubulin (Sigma),
-tubulin (Sigma), aurora B (Abcam or BD Biosciences), BubR1 (a gift
from S. S. Taylor, University of Manchester, UK), Mad2 [a gift of E.
Salmon (University of North Carolina, USA) or K. Wassmann (CNRS,
France)], cyclin B1 (Santa Cruz Biotechnology), incenp (a gift of C.
Rodriguez, Hospital Puerta del Mar, Spain) and phospho-histone H3 Ser10
(P-H3; Upstate Biotechnologies). The corresponding secondary antibodies
were from Molecular Probes (Invitrogen). Images were obtained using a
confocal ultra-spectral microscope (Leica TCS-SP5).
For immunodetection in protein lysates, cells were lysed in RIPA buffer
supplemented with protease and phosphatase inhibitory cocktails (Sigma).
Proteins were separated on SDS-PAGE, transferred to nitrocellulose
membranes (BioRad), and probed using specific antibodies against aurora
B (BD Transduction and Abcam), incenp (Abcam), Mad2 (MBL), GFP
(Roche) and -tubulin (Sigma). For immunoprecipitation, total protein
lysates were pre-cleared with protein-G-agarose beads (Amersham) and
incubated with mouse anti-GFP (Roche). Immunoprecipitates were then
washed three times in RIPA buffer and used for immunodetection.
RESULTS
Generation of aurora B mutant mice
To generate an Aurkb null allele we first flanked exons 2-6 with
loxP sequences using an frt-neo (neomycin-resistant gene)-frt
cassette for selection purposes as indicated in Fig. 1A. In
addition, we also generated a knock-in allele, Aurkb(Z), in which
expression of the endogenous Aurkb gene is replaced by lacZ
transcripts encoding -galactosidase (Fig. 1B,C and see Fig. S1
in the supplementary material). The neomycin-resistant cassettes
were removed by crossing with transgenic mice expressing the
Flp recombinase (see Materials and methods) resulting in the
conditional Aurkb(lox) or Aurkb(loxZ) alleles. Germline deletion
of exons was achieved by additional crosses with Tg.CMV-Cre
transgenic mice to generate the Aurkb(–) or Aurkb(Z) alleles.
These two alleles were null for aurora B expression, as detected
by immunofluorescence (see below), and led to similar
phenotypes.
Lack of one allele of aurora B did not result in major alterations
during the proliferation of cultured cells or during development.
Aurkb(+/–) embryonic fibroblasts proliferated well in culture and did
not display obvious defects during cell cycle progression (see Fig.
S2 in the supplementary material). Similarly, Aurkb(+/–) mice
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developed normally and were fertile. However, a few Aurkb(+/–)
males (16.6% incidence) developed oligospermia by 12 months of
age (see Fig. S3 in the supplementary material), in agreement with a
relevant role of aurora B during spermatogenesis (Kimmins et al.,
2007). In addition, Aurkb(+/–) mice displayed a shorter life span
owing to an increase in spontaneous pathologies (Fig. 1D). In
particular, these mutant mice displayed a significant increase in the
number of tumors, including pituitary and liver adenocarcinomas or
skin papillomas that were not observed in the control group (Fig. 1E
and see Fig. S3 in the supplementary material). Lack of one allele of
aurora B resulted in a slight, although not significant, protection
against 3-MC-induced fibrosarcomas or DMBA+TPA-induced skin
tumors (see Fig. S4 in the supplementary material). These results are
similar to those obtained with other models with alteration in specific
mitotic regulators suggesting that genomic instability caused by these
mutations might increase tumor development in old mice but might
be protective against rapid, induced tumors due to proliferative
defects (Garcia-Higuera et al., 2008; Weaver and Cleveland, 2009).
Genetic ablation of aurora B does not disturb
early embryonic divisions
To generate homozygous mutants, we intercrossed Aurkb(+/–) or
Aurkb(+/Z) mice and analyzed their progeny. No homozygous
mutant was born and no homozygous embryos were observed at
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Fig. 1. Characterization of aurora B-deficient mice. (A)Schematic of the Aurkb alleles used in this study. The mouse Aurkb locus encoding
aurora B contains eight exons (boxes) containing non-coding (open boxes) or protein-coding (gray boxes) sequences. Wild-type loxP (white
triangles) and frt (black triangles) sites are used to flank aurora B exons or the neo-resistance cassette (black) in the targeting vector. The neo
cassette is eliminated in vivo by crossing Aurkb(+/loxfrt) mice with transgenic mice expressing the Flp recombinase. Further excision of exons 2-6 is
mediated by expression of the Cre recombinase resulting in the Aurkb(–) null allele. The position of oligonucleotides used for genotyping is shown
as numbered arrows (see Fig. S1 in the supplementary material). HR, homologous recombination. (B)The Aurkb(Z) allele contains an IRES-lacZ
cassette (blue) instead of aurora B exons 2-4. This cassette contains poly-A sequences for termination of transcription but it does not include any
promoter sequence. Instead, it is preceded by a spliced acceptor resulting in the expression of -galactosidase (encoded by the lacZ gene) driven by
the aurora B regulatory sequences. Wild-type (white triangles) and mutant (gray triangles) loxP sites are flanking this cassette as a consequence of
the targeting strategy (see Fig. S1 in the supplementary material for details). (C)Southern blot analysis of recombinant embryonic stem (ES) cells
showing two Aurkb(+/loxfrt) clones that underwent HR. DNA was digested with ScaI and hybridized with the probe 5- (see Fig. 1A) or neo-specific
sequences. The corresponding analysis for the Aurkb(Z) allele is shown as in Fig. S1 in the supplementary material. (D)Survival curve of Aurkb(+/+)
and Aurkb(+/–) mice indicating a slight but significant reduction in the life span of these mutant mice. (E)This lethality is accompanied by a
significant increase in the percentage of tumor-bearing mice in 24-month-old mice. The specific pathologies found in these animals are shown in
Fig. S3A in the supplementary material. n indicates the number of mice of each genotype analyzed in these assays.
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mid gestation, suggesting early embryonic lethality (see Table S1
in the supplementary material). Because genetic ablation of the
other CPC components, incenp, borealin or survivin, prevents
embryonic cell divisions as early as E2.5 (Cutts et al., 1999;
Uren et al., 2000; Yamanaka et al., 2008), we decided to isolate
fertilized embryos at E2.0. By this stage, most embryos were at
the 4-cell stage (Fig. 2A). After four additional days in culture,
wild-type embryos formed normal morulas and blastocysts.
Unexpectedly, Aurkb(–/–) embryos also formed blastocysts in
vitro without any evident sign of decreased size or cellular death.
We tested whether this kinase is expressed at these
developmental stages and we observed that this protein is
detected at the expected cellular structures (centromeres, spindle
midzone and cytokinesis bridges) in early Aurkb(+/?) [either
wild-type or Aurkb(+/–)] embryos. Aurora B, however, was not
detected in fertilized Aurkb(–/–) embryos at the 2-cell stage (see
Fig. S5 in the supplementary material) or at later developmental
phases (Fig. 2B-D). Thus, the lack of defects in Aurkb(–/–)
morulas or blastocysts is not a consequence of uncontrolled
expression of aurora B or maternal contribution but rather an
indication of the dispensability of aurora B during cell division
at these stages. Intriguingly, aurora B-null morulas displayed
normal phosphorylation of histone H3 (P-H3; Fig. 2B) and the
expected localization of CPC components such as incenp, which
colocalizes with aurora B in wild-type and aurora B-null mitotic
figures (n12 per genotype; Fig. 2C). After two days in culture,
wild-type and Aurkb(–/–) blastocysts displayed similar size, cell
number and P-H3 staining despite the absence of aurora B in
mutant embryos (Fig. 2D and see Fig. S6 in the supplementary
material).
Lack of aurora B prevents proper chromosome
segregation in the inner cell mass
After a few extra days in culture, wild-type blastocysts hatched
from the zona pellucida, attached to the culture dish and generated
a normal and proliferative (as indicated by P-H3 staining) inner cell
mass (ICM) outgrowth surrounded by trophoblast giant cells (Fig.
3A). Lack of aurora B resulted in a reduced number of trophoblasts
with altered nucleus size and morphology (see Fig. S7 in the
supplementary material) and deficient ICM outgrowth (Fig. 3A).
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Fig. 2. Normal development of pre-implantation
embryos lacking aurora B. (A)E2 embryos were isolated
from intercrosses between Aurkb(+/–) mice, cultured for
four additional days and genotyped by PCR.
(B)Colocalization of aurora B (AurB) with phospho-histone
H3 (P-H3) in mitotic cells of E2.5 pre-implantation embryos.
In the absence of aurora B, mitotic cells are also present in
the same frequency and display normal staining for P-H3.
Arrows indicate P-H3-positive cells. (C)Incenp is also
properly localized (arrows) in early embryos in the presence
or absence of aurora B. (D)Wild-type and aurora B-null
embryos form blastocysts in vitro and display normal
mitotic figures (yellow arrows) and cytokinesis bridges
(white arrows) despite of the absence of aurora B. The (+/?)
genotype indicates either (+/+) or (+/–). -tubulin (-tub)
staining is shown in red and DAPI (DNA) in blue. ACA, anti-
centromeric antigen antibody. Scale bars: 20m.
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Immunofluorescence of these mutant cells detected numerous ICM
cells in prometaphase (PM) or metaphase (M) that were only rarely
observed in control cultures (Fig. 3B). Aurora B-deficient cells
displayed abnormal spindles with a strong concentration of -
tubulin in the poles and lack of bipolar fibers (Fig. 3C). Multipolar
spindles were also frequently observed, suggesting either a defect
in organizing bipolar spindles or the presence of polyploid cells.
All these mitotic figures displayed misaligned chromosomes (Fig.
3C-E) in the presence of Mad2 (Mad2l1 – Mouse Genome
Informatics) and cyclin B1 (Fig. 3D). Finally, incenp is properly
located at the metaphase plate and midbodies of wild-type, but not
mutant, cells (Fig. 3E), suggesting that aurora B deficiency results
in impaired CPC function in ICM outgrowths but not during earlier
developmental stages.
Genetic ablation of aurora B results in mitotic
aberrations and lethality after implantation
Aurora B-negative embryos could be found at distinct post-
implantation stages (15.6% at E6.5, 26% at E7.5 and 16% at E9.5;
see Table S1 in the supplementary material; note that embryonic
structures were absent in a percentage of deciduas suggesting
additional dead embryos after implantation). All these implanted
aurora B-deficient embryos displayed small size and a progressive
reduction in the number of cells (Fig. 4 and see Fig. S8 in the
supplementary material). Histological examination of E6.5
embryos revealed defective structures in aurora B-null embryos
accompanied with hemorrhage in the ectoplacental cone and
frequent edemas and apoptotic cells (Fig. 4A,B). This atrophy did
not seem to be due to a defect in specific cell lineages as Sox2-
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Fig. 3. Lack of aurora B results in mitotic
defects in the inner cell mass. (A)Genetic
ablation of aurora B results in abnormal inner cell
mass (ICM; encircled by dashed line) outgrowths
in culture. Whereas Aurkb(–/–) embryos exhibit
abundant trophoblast giant cells (TGC), the ICM
outgrowth is dramatically reduced and phospho-
histone H3 (P-H3) signal is almost undetectable.
Error bars represent s.d. (B)Aurora B (green) is
present in mitotic and cytokinesis figures in wild-
type (arrows and insets) but not in Aurkb(–/–)
embryos. In the absence of aurora B, abundant
mitotic (white arrowheads) and apoptotic (yellow
arrowheads) figures are observed in the ICM
outgrowth. M, metaphase; C, cytokinesis. Scale
bars: 50m. (C)Mitotic distribution in ICM
outgrowths. In wild-type cells, aurora B (green)
localizes internal to anti-centromeric antibody
(ACA) spots (red or white) during prophase (P) or
metaphase (M) owing to its localization to the
inner centromere. Aurora B moves to the central
spindle during telophase (T) or to the cytokinesis
bridge during cytokinesis (C). In Aurkb(–/–)
embryos, aurora B is not detected and these cells
display aberrant bipolar spindles with misaligned
chromosomes (white arrow), as well as
monopolar or multipolar spindles. Note the
presence of multiple poles or isolated -tubulin
spots (yellow arrows). Scale bars: 10m.
(D)Aurkb(–/–) cells show the presence of Mad2
(green) at the kinetochores during prometaphase
(white arrow) or in misaligned chromosomes in
incomplete metaphases (yellow arrow). Cyclin B1
is also present in these mitotic figures showing a
diffuse expression in some cases accompanied by
enrichment at the poles. Scale bars: 10m.
(E)Although incenp is properly localized at the
centromeres (arrow), midbodies or cytokinesis
bridges (not shown) in wild-type cells, no incenp
signal is observed in aurora B-null cells. Scale bars:
10m. For these assays, embryos were isolated at
E2.5 and cultured in vitro for five (B-E) or eight (A)
additional days.
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(epiblast) and Gata4- (primitive endoderm) positive cells were
present in both wild-type and mutant embryos (see Fig. S8 in the
supplementary material).
Aurora B-null embryos displayed a significant increase in
mitotic and apoptotic cells at E6.5-7.5 (Fig. 4B). Many of these
cells displayed positive staining for H2AX (H2afx – Mouse
Genome Informatics), p53 (Trp53 – Mouse Genome Informatics)
and active caspase 3 (C3A), suggesting DNA damage and
activation of the p53 pathway in these cells (Fig. 4C). Interestingly,
most of these mitotic figures represented cells in PM and M,
including abnormal PM/M figures with misaligned chromosomes
(Fig. 4D,E). Most of these mitotic cells displayed a positive signal
for cyclin B1, suggesting that anaphase promoting complex
(APC/C)-Cdc20 has not been activated. By E9.5, most embryos
were degenerated and only displayed either mitotic or apoptotic
cells (see Fig. S8 in the supplementary material).
Aurora C is sufficient to drive mitotic progression
during early embryonic development
As lack of the other CPC components, incenp, survivin or borealin,
results in early lethality by E2.5 (Cutts et al., 1999; Uren et al.,
2000; Yamanaka et al., 2008), we wondered whether aurora B
could be dispensable owing to the presence of other aurora kinases
during early embryonic development. Indeed, aurora C has been
shown previously to bind other CPC components when
overexpressed in specific cell lines (Sasai et al., 2004; Slattery et
al., 2009; Slattery et al., 2008; Yan et al., 2005). As depicted in Fig.
5A,B, aurora C was detected in early embryos (2-cell stage and
morulas) and in testis but it was not expressed in late embryos, as
examined by RT-PCR or immunostaining in sections. Further
analysis of aurora C expression in adult tissues indicated a
significant expression in testis (Fig. 5B), as reported previously (Hu
et al., 2000; Kimmins et al., 2007; Tang et al., 2006). Similar data
indicating expression of aurora C in early embryos, but not in later
stages or most somatic tissues, can be obtained from published
expression profiles (Hamatani et al., 2004) and public databases
(see Fig. S9 in the supplementary material). Aurora C is also
expressed in interphasic brain glial cells but we did not detect
significant expression of this protein in most of the other tissues
analyzed in a human tissue array (see Fig. S9 in the supplementary
material).
Next, we treated embryos with a small molecule inhibitor,
ZM447439 (frequently abbreviated as ZM1), that is able to
efficiently inhibit both aurora B and C kinases [IC50 aurora B 50
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Fig. 4. Post-implantation lethality in aurora B-
deficient embryos. (A)Abnormal embryonic
development of aurora B-null embryos by E6.5.
Aberrant ectoplacental cones with degenerative
cells and hemorrhage are frequently observed in
aurora B-null embryos (A; arrows). These mutant
embryos also display apoptotic cells in the
exocoelomic cavity (A; asterisk). Scale bars:
500m (blue) or 100m (black). (B)Aurora B-null
embryos at E6.5-7.5 are accompanied by
significant increase in mitotic (Mit.) and apoptotic
(Apop.; arrows in A) figures. (C)Increase in the
number of cells positive for p53, H2AX or active
caspase 3 (C3A) immunostaining (positive cells are
indicated by black arrows) in the absence of
aurora B. Scale bars: 100m (p53) or 20m
(H2AX and C3A). (D)Aurora B is readily
detectable in mitotic figures (arrows) of
Aurkb(+/?) but not Aurkb(–/–) cells. As a control
for specific aurora B staining, an
anaphase/telophase cell negative for aurora B
chromosomal staining is shown (arrowhead, top
left panel). Abnormal mitotic figures are also
observed in aurora B-null embryos (arrowhead,
bottom left panel). In wild-type cells, cyclin B1 is
present in prometaphase figures (arrow) but not in
advanced metaphase or anaphase/telophase
stages (arrowheads). Normal (arrows) or abnormal
(arrowhead) mitotic figures in Aurkb(–/–) embryos
display a positive staining for cyclin B1. Scale bars:
20m. (E)Quantification of the distribution of
mitotic cells in the different phases of mitosis.
Abnormal mitotic figures that are not observed in
wild-type embryos mostly correspond to cross-
shaped mitosis as shown in D. For all graphs,
asterisks indicate P<0.001 or P<0.05 (mitosis at
E6.5), n is the number of cells counted in these
embryos and error bars represent s.d.
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nM; IC50 aurora C 250 nM (Girdler et al., 2006)]. Wild-type E1.5
(2-cell) embryos were treated with different ZM1 doses (0.5, 1, 2,
5, 20 and 100 m) or carrier and analyzed 24 and 48 hours later.
As represented in Fig. 5C and Fig. S10 in the supplementary
material, ZM1 treatment from 5 to 20 M resulted in a severe
arrest at the 2 to 4-cell stage in nearly all of treated embryos.
Importantly, treatment with ZM1 resulted in a phenotype similar to
that observed in aurora B-deficient embryos by E7.5, including
aberrant prometaphase figures with misaligned chromosomes and
tetraploid cells (Fig. 5D). To explore further the possibility that
aurora C is responsible for supporting cell division during the
morula and early blastocyst stage, we microinjected three short
hairpin interfering RNAs (shRNAs) specific for aurora B or aurora
C kinases, along with a reporter plasmid that expresses the green
fluorescent protein (GFP) fused to histone H2B (Fig. 6A). One day
after microinjection, most embryos were at the 2-cell stage and
expressed the fusion protein GFP-H2B in the nucleus of these
embryonic cells (Fig. 6B). After three days in culture, most
embryos injected with a shRNA against luciferase or Aurora B
progressed normally forming morulas with 4-8 cells. However,
most embryos injected with aurora C shRNAs or a combination of
aurora B and aurora C shRNAs were arrested at the 2-cell stage
(Fig. 6B). These embryos displayed a high number of mitotic
figures, mostly PM or M by day 3 (Fig. 6C) as previously
described in the aurora B-deficient inner cell mass. These abnormal
divisions frequently resulted in chromosomal bridges and giant
nuclei, suggesting a defect in cytokinesis (Fig. 6D) resulting in an
arrest at the 2-4 cell stage (Fig. 6D). Taken together, these results
suggest that aurora C, but not aurora B, has a crucial role in driving
proper cell division during early embryonic development.
Aurora B is required for chromosome congression
but it is not essential for the spindle assembly
checkpoint
We took advantage of the conditional Aurkb(lox) allele to analyze
the cellular effects of the acute deletion of aurora B in cultured cells
that do not express aurora C. Primary Aurkb(lox/lox) MEFs were
isolated from E14.5 embryos and cultured in complete medium.
Aurora C was not expressed in these mid-gestation embryos or in
immortal fibroblasts derived from them (Fig. 5A and see Fig. S9 in
the supplementary material). Confluent MEFs were infected with
adenoviruses expressing either GFP (AdGFP) or the Cre
recombinase (AdCre) in the presence of low serum (0.1% FBS)
and seeded in 10% FBS at low confluency 48 hours later (t0) to
allow cells to enter into a new cell cycle (Fig. 7A). Expression of
Cre, but not GFP, resulted in an almost complete deletion of exons
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Fig. 5. Aurora C is expressed in early zygotes and cell
division is sensitive to aurora B/C small molecule
inhibitors during early cell divisions. (A)Expression of
aurora C at the 2-cell stage, morula, mid-gestation (E14.5) or
adult mouse tissues as measured by real-time RT-PCR. mRNA
levels were normalized relative to the expression of GADPH.
(B)Detection of aurora C by immunohistochemistry in paraffin
sections (E7.5) from wild-type (left) or aurora B-deficient
(middle) post-implantation embryos indicating lack of
expression at this stage. Aurora C is not detected in most
adult tissues (see Fig. S9 in the supplementary material) but it
is highly expressed in germ cells of the testis (right-hand
panel). Inset shows a detail of aurora C-positive germ cells.
(C)Sensitivity of embryos at the 2-cell stage (n20 per group)
to different doses of ZM1, a small-molecule inhibitor of
aurora B and aurora C (see also Fig. S10 in the supplementary
material). (D)Immunofluorescence analysis at day 1 indicates
a significant accumulation of cells in mitosis (white arrows) or
in cytokinesis, generation of polyploid cells (yellow arrows)
with a subsequent reduction in the number of cells per
embryo in ZM1-treated cells. Phosphorylation of histone H3
(P-H3) is significantly reduced in these ZM1-treated mitotic
cells although some signal is still detected. Scale bars: 20m.
n indicates the number of embryos scored in the different
assays. For all graphs, error bars represent s.d.
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2-6 [Aurkb() allele; Fig. 7B]. Aurora B-deficient cells underwent
mitosis and accumulated as 4N or >4N DNA content cells after
expression of the Cre recombinase (Fig. 7C). Examination of these
cultures by immunofluorescence 48 hours after serum stimulation
indicated an efficient elimination of aurora B at the protein level in
Cre-infected cells (Fig. 7D). As cells are infected with Cre in G0
and are maintained in G0 for two additional days before entering
into G1, this protocol ensures the degradation of residual aurora B
proteins, possibly by APC/C-Cdh1 complexes. The residual
Aurkb(lox) allele seen in Fig. 7B therefore indicates residual cells
in which Cre was not active and Aurora B was still present (as
identified by immunofluorescence; not shown) rather than residual
aurora B protein in Aurkb(/) cells. Lack of aurora B was
accompanied by a massive accumulation of abnormalities,
including multiple nuclei, micronuclei and apoptotic figures, as
well as lack of cytokinesis (Fig. 7D-F). About 25% of aurora B-
deficient cells displayed an accumulation of -tubulin asters that
were either connected to chromosomes in multipolar cells or not
connected to chromosomes (‘multiaster’ phenotype; Fig. 7G,
arrowheads). The multiple microtubule organizing centers
(MTOCs) might also explain monopolar spindles as these figures
frequently contain multiple -tubulin spots grouped around the
single pole (see Fig. S11 in the supplementary material).
Aurora B is essential for the error correction mechanism
required for full chromosome alignment in metaphase. During this
function, aurora B can generate unattached kinetochores thus
resulting in unsatisfied SAC and mitotic arrest. It is, however,
currently controversial to what extent aurora B might directly
regulate the SAC independent of the error-correction mechanism.
We therefore tested mitotic arrest in the presence of 3.5 M of
nocodazole, a condition under which microtubules are not formed.
In wild-type MEFs, the duration of mitosis (DOM) was 435±135
minutes in the presence of nocodazole, as detected by
videomicroscopy. In the absence of aurora B, the average DOM
was 251±43.5 minutes, indicating a clear arrest when comparing
with cells treated with DMSO (52±15 minutes) (Fig. 8A). This
nocodazole-induced arrest is, however, smaller than that induced
in wild-type cells, suggesting certain impairment in building a
robust SAC response. The arrest can be partially overcome by
Mad2 downregulation, suggesting an SAC-dependent delay both
in wild-type and aurora B-deficient cells (Fig. 8A,B). Aurora B-
null cells displayed a partial defective localization of BubR1
(Bub1b – Mouse Genome Informatics) to unattached kinetochores
in the presence of nocodazole whereas Mad2 was properly
localized (Fig. 8C), in agreement with the data in early embryos
(Fig. 3). The genetic disruption of aurora B therefore supports the
hypothesis that aurora B is not completely essential for the SAC,
although it might directly participate in the recruitment of BubR1
to unattached kinetochores.
Aurora C can compensate for the lack of aurora B
in somatic cells
We next tested whether the abnormalities caused by the absence of
aurora B could be rescued by the expression of aurora C.
Aurkb(lox/lox) cells were first infected with AdCre to generate
Aurkb(/) cells (day 2 in Fig. 7A) and these cells were then
transfected (day 4 in Fig. 7A) with GFP-fusion constructs
expressing wild-type aurora B or aurora C or a kinase-dead form
of these proteins. As represented in Fig. 9, the elimination of aurora
B resulted in an aberrant mitotic distribution with almost inexistent
anaphase or telophase figures (Fig. 9A). The expression of
exogenous wild-type, but not kinase-dead, aurora B rescued the
defects, and Aurkb(/);GFP-AurBWT cultures displayed a normal
ratio of cells in anaphase, telophase or cytokinesis (Fig. 9B-D). The
exogenous GFP-tagged protein was properly located at cytokinesis
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Fig. 6. Knock down of aurora C but not aurora B results in cell
cycle arrest in early embryonic development. (A)Schematic of the
protocol followed for knocking down aurora B and/or aurora C in
zygotes. Embryos were isolated at E0.5 and microinjected with vectors
expressing short hairpin interfering RNAs (shRNAs) against luciferase
(shLuc) and aurora B (shAurB) and/or aurora C (shAurC), as well as a
plasmid expressing H2B-GFP. qRT-PCR analysis shows a clear
downregulation of aurora C in these assays and a more modest
reduction of aurora B. However, it is important to note that aurora B
mRNA levels are close to background levels at this stage and close to
the limits of mRNA detection in these assays. (B)Microscopy images
(combined bright field and green fluorescence) of embryos treated with
these shRNAs indicating an arrest at the 2- to 4-cell stage in embryos
treated with shAurC, shAurB-shAurC, but not shAurB or embryos
treated with shRNAs against luciferase (not shown). Scale bars: 20m.
Insets show representative embryos. (C)Knock down of aurora C (shC)
or aurora B+aurora C (shB+C) results in a significant increase in mitotic
cells in most cases showing misaligned chromosomes (white arrows). By
day 3, most treated embryos display polyploid cells as well as
cytokinesis bridges or micronuclei (yellow arrows).
(D)Immunofluorescence analysis of these zygotes by day 3 shows
mitotic aberrations and apoptotic figures after microinjection of shAurC
or shAurB+AurC. These embryos arrest at the 2- or 4-cell stage whereas
shAurB or shLuc embryos show an average of eight cells per embryo.
Scale bars: 10m. For all graphs, error bars represent s.d.
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bridges in these cells (Fig. 9C). Interestingly, expression of wild-
type, but not kinase-dead, aurora C resulted in a similar phenotypic
rescue (Fig. 9B-D) and aurora C was able to interact with incenp
in these cells (Fig. 9E).
DISCUSSION
Mammalian aurora B and C are two closely related paralogs that
probably evolved from a duplication event involving the ancestral
aurora B/C found in cold-blood vertebrates (Brown et al., 2004).
Aurora B is widely expressed in dividing cells. Aurora C, however,
displays a very restricted expression pattern with a clear abundance
during spermatogenesis and oocyte fertilization (Fig. 5 and see Fig.
S7 in the supplementary material). Aurora C deficiency results in
viable mice with subfertility defects, such as heterogeneous
chromatin condensation, loose acrosomes and blunted sperm heads
(Kimmins et al., 2007). Interestingly, aurora C displays frameshift
mutations in infertile patients with abnormal spermatozoa
characterized by large heads and increased chromosomal content
(Dieterich et al., 2007), suggesting a crucial role in mammalian
spermatogenesis. Additional loss-of-function studies of aurora C in
oocytes suggest specific roles for this protein in meiosis (Sharif et
al., 2010; Yang et al., 2010). However, its relevance in CPC
function and mitosis in vivo has not been elucidated given the
reduced endogenous expression levels in cultured cell lines.
The fact that aurora B-null embryos survive up to post-
implantation stages is certainly surprising given the earlier lethality
of incenp, survivin or borealin-deficient embryos (Cutts et al.,
1999; Uren et al., 2000; Yamanaka et al., 2008) and the crucial
roles of the CPC in cell division. During pre-implantation, incenp
is properly located in the absence of aurora B and the phenotypes
expected from perturbed CPC function are not observed. However,
these embryos are sensitive to aurora B/C inhibitors such as ZM1.
Aurora C expression is higher than that of aurora B during these
early stages (Fig. 6) and the interference of aurora C results in cell
division defects in early zygotes [our data and Lykke-Andersen et
al. (Lykke-Andersen et al., 2008)]. The fact that aurora C-null
embryos develop normally (Kimmins et al., 2007) might be
explained by the presence of maternal aurora C in these embryos.
Indeed, the aurora B/C ancestor was recently described to be an
essential maternal-effect gene in zebrafish (Yabe et al., 2009). In
addition, the mouse genome contains several aurora C loci
originally considered to be pseudogenes but that might express
functional proteins (Yang et al., 2010) thus making difficult to
evaluate a loss-of-function aurora C mutant in this organism. Lack
of aurora A results in lethality at the morula/blastocyst stage due to
defective formation of a mitotic bipolar spindle, thus confirming
the functional differences between aurora A and aurora B/C in vivo
(Ang et al., 2008; Cowley et al., 2009; Sasai et al., 2008). Together,
these results suggest that aurora C is the major CPC kinase during
these early cell divisions in vivo.
Conditional ablation of aurora B in primary MEFs reveals a
crucial role for this kinase in chromosome congression, as
previously described (Ditchfield et al., 2003; Hauf et al., 2003;
Vader et al., 2007). These mitotic defects can be rescued by
expressing wild-type, but not kinase-dead, aurora C. Indeed, aurora
C interacts with incenp and seems to act as a CPC component
when exogenously expressed (our results) (Sasai et al., 2004;
Slattery et al., 2009; Slattery et al., 2008; Yan et al., 2005). These
data, along the relevance of aurora C during meiosis (Dieterich et
al., 2007; Sharif et al., 2010; Yang et al., 2010) and in the early cell
divisions (this work) indicate that aurora C has crucial roles in
vivo, at least in germ cells and during early embryo development.
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Fig. 7. Cellular phenotypes following acute deletion of aurora B in
mouse embryo fibroblasts (MEFs). (A)Schematic of the protocol
followed for acute ablation of aurora B in G0-arrested cells. Aurkb(lox/lox)
cells are arrested in low serum and confluence and transduced with
AdGFP or AdCre vectors. Forty-eight hours later, cells are split into new
medium supplemented with 10% fetal bovine serum to induce entry into
the cell cycle. Samples are taken at 48 hours for immunofluorescence (IF)
or at 72 hours for fluorescence-activated cell sorting (FACS) analysis.
(B)Representative PCR showing the generation of the Aurkb() null allele
48 hours after Cre expression. The Aurkb(lox) allele is genotyped using
oligonucleotides 2 and 3 (see. Fig. 1), whereas primers 1 and 3 are used
to genotype the Aurkb() null allele. (C)Infection with AdCre in primary
MEFs results in an accumulation of 4N and >4N cells 72 hours after the
exit from quiescence as detected by propidium iodide staining and flow
cytometry. (D)Examination of these cultures by immunofluorescence at
48 hours indicates efficient depletion of aurora B (green in merge) in
AdCre-infected cells. These mutant cells display aberrant morphologies as
identified by staining with -tubulin antibodies (red in merge) and DAPI
(DNA) staining (blue in merge). (E)Aurkb(/) primary MEFs display an
accumulation of abnormal interphase cells, including cells with several
nuclei or micronuclei (see image) and apoptotic cells. (F)In addition, there
is a dramatic reduction in cytokinesis figures suggesting a defect in the
later stages of cell division. The remaining cytokinesis figures in
Aurkb(/) cells are usually abnormal with long chromosomal bridges
(arrows). n indicates the number of cells counted for each genotype.
(G)Ablation of aurora B results in multiple spindle poles that might cluster
forming monopolar spindles. Some of the multiple -tubulin spots might
display a robust nucleation of microtubules (multiaster phenotype;
arrows). Scale bars: 10m. DE
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Loss-of-function studies of mammalian aurora B have typically
used RNA interference or small-molecule chemical inhibitors
(Ditchfield et al., 2003; Hauf et al., 2003; Ruchaud et al., 2007).
These studies have the caveat that the elimination of this protein
might be incomplete and residual kinase activity might support
certain activities. For instance, aurora B-null cells do not reach
anaphase, suggesting that previous anaphase figures or abnormal
cytokinesis observed upon RNA interference are likely to be due
to partial inhibition. Although we cannot discard a minimum trace
of aurora B kinase activity in Aurkb(/) cells, genetic disruption
of aurora B in G0 results in the strongest defects reported so far in
the mitosis that follows. Yet, aurora B-null cells display a
significant arrest in nocodazole, suggesting that this kinase is not
essential for the SAC. As aurora B-deficient cells display
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Fig. 9. Functional rescue of aurora B-null cells by aurora C.
(A)Mitotic distribution in control Aurkb(lox/lox) (n1234 cells) or
Aurkb(/) (n1141) primary mouse embryo fibroblasts (MEFs; 48 hours
after the expression of Cre). The percentage of mitotic cells (versus the
total number of cells in the culture) and the percentage of mitotic cells in
prophase (P), prometaphase (PM), metaphase (M), anaphase (A) and
telophase (T) are represented. (B)Aurkb(/) cells were transfected 2 days
after AdCre (day 4 in Fig. 7A) with plasmids expressing GFP (empty
vector, EV); or GFP-fusion proteins containing wild-type aurora B
(AurBWT), aurora C (AurCWT), or kinase-dead mutant forms of these
proteins (AurBKD and AurCKD). (C)Representative images of Aurkb(/)
cultures in the presence of the empty vector (GFP; left) or the different
GFP-aurora B or aurora C fusion proteins. Both GFP-AurBWT- and GFP-
AurCWT-expressing cells reach cytokinesis with proper localization of the
exogenous GFP-AurB/C fusion protein to cytokinesis bridges (green
arrows). However, most mitotic cells expressing the kinase-dead (KD)
mutants display prometaphase figures typical of aurora B-null cells with
multipolar spindles (white arrows). Scale bars: 10m. (D)Percentage of
cytokinesis figures in the indicated cultures. n250 cells were scored for
each of the different cultures in B and C. Error bars represent s.d.
(E)Interaction between GFP-tagged aurora B and aurora C with incenp in
Aurkb(lox/lox) and Aurkb(/) MEFs. GFP-Aurora proteins were
immunoprecipitated 48 hours after transfection using anti-GFP antibodies
and immunoblotted with antibodies against incenp or GFP. Both aurora B
and aurora C form conjugates with incenp.
Fig. 8. Genetic ablation of aurora B does not prevent mitotic
arrest in the presence of nocodazole. (A)Duration of mitosis (in
minutes) in primary Aurkb(lox/lox) or Aurkb(/) mouse embryo
fibroblasts (MEFs) in the absence or in the presence of 3.5M
nocodazole (Noc). Knock down of Mad2 expression by small interfering
RNA (siRNA) was performed to inactivate the spindle assembly
checkpoint (SAC) upon nocodozale treatment. (B)Mad2 protein levels
are partially diminished in Aurkb(lox/lox) and Aurkb(/) cells, as shown
by immunoblotting. (C)Localization of BubR1 and Mad2 to
kinetochores in the presence of nocodazole. The ratio between BubR1
(n88 per genotype) or Mad2 (n22) and anti-centromere antibody
(ACA; centromere) signals is shown. Representative images of BubR1 or
Mad2 signals (green) in nocodazole-treated Aurkb(lox/lox) and
Aurkb(/) cells. ACA is shown in red and DNA (DAPI) in blue. The -
tubulin signal (red) indicates lack of microtubules in cells treated with
3.5M nocodazole. Scale bars: 10m.
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inefficient localization of BubR1 (Fig. 8) (Ditchfield et al., 2003;
Hauf et al., 2003), this kinase might partially contribute, possibly
as a separate arm (Morrow et al., 2005), to the SAC response by
recruiting BubR1 to unattached kinetochores.
Aurora kinases have recently received much attention owing to
their possible involvement in tumor development and their
potential therapeutic value (Keen and Taylor, 2004; Lens et al.,
2010; Perez de Castro et al., 2008). Whereas initial efforts were
focused on aurora A, recent data suggest that aurora B is a relevant
cancer target (Girdler et al., 2006; Girdler et al., 2008). In addition,
the ability of aurora C to drive CPC function suggests the relevance
of this protein in specific cell types. Intriguingly, whereas no point
mutations have been reported for aurora B, four mis-sense changes
in aurora C (G18E, G53A, E114Q and H210Q) have been found in
lung adenocarcinomas (Davies et al., 2005; Forbes et al., 2008).
Some of these changes affect the P-loop or activation segment of
the kinase domain, a conserved and key functional region known
to harbor activating somatic mutations in other kinases in cancer
(Davies et al., 2005). Understanding the specific requirements for
aurora B/C in different cell types might, therefore, provide useful
information for future therapeutic efforts.
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